{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T08:35:27Z","timestamp":1769589327149,"version":"3.49.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T00:00:00Z","timestamp":1684368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T00:00:00Z","timestamp":1684368000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2023,11]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The link between human leukocyte antigen (HLA) alleles and carbamazepine-induced cutaneous, respiratory, and gastrointestinal adverse drug reactions (ADR) has created a window of opportunity for preventing certain forms of cutaneous adverse drug reactions (cADRs); however, there is not enough data to make pharmacogenomic recommendations that can be implemented globally. The aim of this study is to assess and document carbamazepine-induced adverse reactions among prescribed Saudi\/non-Saudi patients. A retrospective chart review was performed for patients who received carbamazepine (CBZ) in the period between 2016 and 2020, in the Kingdom of Saudi Arabia. Data were gathered and descriptive statistical analyses were performed on the data for the study sample. Comparisons were made using the chi-square test or independent samples\u2019 <jats:italic>t<\/jats:italic>-test. Statistical significance was considered at <jats:italic>p<\/jats:italic>\u2009&lt;\u2009.05. All statistical analyses were performed using IBM SPSS 21.0 (Armonk, NY; IBM Corp). Results from multivariate logistic regression analyses showed that higher likelihood of carbamazepine-induced adverse reactions was significantly associated with younger age, OR\u2009=\u20090.82, 95% CI (0.74, 0.90); <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001. Patients who were prescribed CBZ for reasons other than epilepsy or seizures were significantly more likely to develop carbamazepine-induced adverse reactions (epilepsy vs. other; OR\u2009=\u20090.63, <jats:italic>p<\/jats:italic>\u2009=\u20090.013; seizures vs. other; OR\u2009=\u20090.59, <jats:italic>p<\/jats:italic>\u2009=\u20090.018). Gender or medication duration were not related to carbamazepine-induced adverse reactions (<jats:italic>p<\/jats:italic>\u2009&gt;\u20090.05). The findings of this study are comparable with those of other studies assessing carbamazepine-associated adverse reactions in children and adults. Recommendations include genetic prescreening, educating patients and parents on the possibility of adverse reactions, and routine laboratory monitoring.\n<\/jats:p>","DOI":"10.1007\/s00210-023-02525-2","type":"journal-article","created":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T11:03:03Z","timestamp":1684407783000},"page":"3177-3182","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["A highlight on carbamazepine-induced adverse drug reactions in Saudi Arabia: a retrospective medical records-based study"],"prefix":"10.1007","volume":"396","author":[{"given":"Hatouf H.","family":"Sukkarieh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayesha A.","family":"Khokhar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rami T.","family":"Bustami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gulsan A.","family":"Karbani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatimah A.","family":"Alturki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Syed N.","family":"Alvi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,5,18]]},"reference":[{"issue":"4","key":"2525_CR1","first-page":"372","volume":"106","author":"VJ Anttila","year":"1990","unstructured":"Anttila VJ, Valtonen M (1990) Karbamatsepiinin aiheuttama vesiripuli ja eosinofiilinen koliitti [Carbamazepine-induced diarrhea and eosinophilic inflammation of the colon]. Duodecim; Laaketieteellinen Aikakauskirja 106(4):372\u2013374","journal-title":"Duodecim; Laaketieteellinen Aikakauskirja"},{"issue":"1","key":"2525_CR2","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1111\/j.1528-1157.1992.tb02293.x","volume":"33","author":"VJ Anttila","year":"1992","unstructured":"Anttila VJ, Valtonen M (1992) Carbamazepine-induced eosinophilic colitis. Epilepsia 33(1):119\u2013121. https:\/\/doi.org\/10.1111\/j.1528-1157.1992.tb02293.x","journal-title":"Epilepsia"},{"issue":"6","key":"2525_CR3","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1016\/s0016-5107(04)02233-3","volume":"60","author":"RJ Atkinson","year":"2004","unstructured":"Atkinson RJ, Dennis G, Cross SS, McAlindon ME, Sharrack B, Sanders DS (2004) Eosinophilic colitis complicating anti-epileptic hypersensitivity syndrome: an indication for colonoscopy? Gastrointest Endosc 60(6):1034\u20131036. https:\/\/doi.org\/10.1016\/s0016-5107(04)02233-3","journal-title":"Gastrointest Endosc"},{"issue":"3","key":"2525_CR4","doi-asserted-by":"publisher","first-page":"177","DOI":"10.2165\/00003088-198611030-00001","volume":"11","author":"L Bertilsson","year":"1986","unstructured":"Bertilsson L, Tomson T (1986) Clinical pharmacokinetics and pharmacological effects of carbamazepine and carbamazepine-10, 11-epoxide. An update. Clinical pharmacokinetics 11(3):177\u2013198. https:\/\/doi.org\/10.2165\/00003088-198611030-00001","journal-title":"Clinical pharmacokinetics"},{"issue":"12","key":"2525_CR5","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1124\/dmd.105.006866","volume":"33","author":"HZ Bu","year":"2005","unstructured":"Bu HZ, Kang P, Deese AJ, Zhao P, Pool WF (2005) Human in vitro glutathionyl and protein adducts of carbamazepine-10,11-epoxide, a stable and pharmacologically active metabolite of carbamazepine. Drug Metab. Dispos. Biological Fate of Chemicals 33(12):1920\u20131924. https:\/\/doi.org\/10.1124\/dmd.105.006866","journal-title":"Drug Metab. Dispos. Biological Fate of Chemicals"},{"issue":"4","key":"2525_CR6","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1378\/chest.68.4.580","volume":"68","author":"SA Cullinan","year":"1975","unstructured":"Cullinan SA, Bower GC (1975) Acute pulmonary hypersensitivity to carbamazepine. Chest 68(4):580\u2013581. https:\/\/doi.org\/10.1378\/chest.68.4.580","journal-title":"Chest"},{"issue":"2","key":"2525_CR7","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1111\/j.1651-2227.1984.tb09948.x","volume":"73","author":"LF De Swert","year":"1984","unstructured":"De Swert LF, Ceuppens JL, Teuwen D, Wijndaele L, Casaer P, Casteels-Van Daele M (1984) Acute interstitial pneumonitis and carbamazepine therapy. Acta Paediatr Scand 73(2):285\u2013288. https:\/\/doi.org\/10.1111\/j.1651-2227.1984.tb09948.x","journal-title":"Acta Paediatr Scand"},{"issue":"12","key":"2525_CR8","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.1111\/j.1528-1157.1999.tb01598.x","volume":"40","author":"IA Eland","year":"1999","unstructured":"Eland IA, Dofferhoff AS, Vink R, Zondervan PE, Stricker BH (1999) Colitis may be part of the antiepileptic drug hypersensitivity syndrome. Epilepsia 40(12):1780\u20131783. https:\/\/doi.org\/10.1111\/j.1528-1157.1999.tb01598.x","journal-title":"Epilepsia"},{"key":"2525_CR9","doi-asserted-by":"publisher","first-page":"3186328","DOI":"10.1155\/2017\/3186328","volume":"2017","author":"WL Fan","year":"2017","unstructured":"Fan WL, Shiao MS, Hui RC, Su SC, Wang CW, Chang YC, Chung WH (2017) HLA association with drug-induced adverse reactions. J Immunol Res 2017:3186328. https:\/\/doi.org\/10.1155\/2017\/3186328","journal-title":"J Immunol Res"},{"issue":"10","key":"2525_CR10","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.2217\/14622416.9.10.1543","volume":"9","author":"PB Ferrell Jr","year":"2008","unstructured":"Ferrell PB Jr, McLeod HL (2008) Carbamazepine, HLA-B*1502 and risk of Stevens-Johnson syndrome and toxic epidermal necrolysis: US FDA recommendations. Pharmacogenomics 9(10):1543\u20131546. https:\/\/doi.org\/10.2217\/14622416.9.10.1543","journal-title":"Pharmacogenomics"},{"key":"2525_CR11","doi-asserted-by":"publisher","unstructured":"Fricke-Galindo I, LLerena A, Jung-Cook H, L\u00f3pez-L\u00f3pez M (2018). Carbamazepine adverse drug reactionsExpert Rev. Clin. Pharmacol. 11(7), 705\u2013718. https:\/\/doi.org\/10.1080\/17512433.2018.1486707","DOI":"10.1080\/17512433.2018.1486707"},{"issue":"6","key":"2525_CR12","first-page":"615","volume":"62","author":"JJ Gayford","year":"1969","unstructured":"Gayford JJ, Redpath TH (1969) The side-effects of carbamazepine. Proc R Soc Med 62(6):615\u2013616","journal-title":"Proc R Soc Med"},{"key":"2525_CR13","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.rmedc.2011.12.001","volume":"5","author":"D Gon\u00e7alves","year":"2012","unstructured":"Gon\u00e7alves D, Moura R, Ferraz C, Vitor AB, Vaz L (2012) Carbamazepine-induced interstitial pneumonitis associated with pan-hypogammaglobulinemia. Respir Med Case Rep 5:6\u20138. https:\/\/doi.org\/10.1016\/j.rmedc.2011.12.001","journal-title":"Respir Med Case Rep"},{"issue":"9","key":"2525_CR14","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1136\/jnnp.50.9.1241","volume":"50","author":"N Harats","year":"1987","unstructured":"Harats N, Shalit M (1987) Carbamazepine induced vasculitis. J Neurol Neurosurg Psychiatry 50(9):1241\u20131243. https:\/\/doi.org\/10.1136\/jnnp.50.9.1241","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"6","key":"2525_CR15","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1111\/j.1365-2125.1986.tb02965.x","volume":"22","author":"N Hockings","year":"1986","unstructured":"Hockings N, Pall A, Moody J, Davidson AV, Davidson DL (1986) The effects of age on carbamazepine pharmacokinetics and adverse effects. Br J Clin Pharmacol 22(6):725\u2013728. https:\/\/doi.org\/10.1111\/j.1365-2125.1986.tb02965.x","journal-title":"Br J Clin Pharmacol"},{"key":"2525_CR16","doi-asserted-by":"publisher","unstructured":"Ianiro G, Cammarota G, Valerio L, Annicchiarico BE, Milani A, Siciliano M, Gasbarrini A (2012). Microscopic colitis. World J. Gastroenterol.,\u00a018(43), 6206\u20136215. https:\/\/doi.org\/10.3748\/wjg.v18.i43.6206","DOI":"10.3748\/wjg.v18.i43.6206"},{"issue":"4","key":"2525_CR17","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.seizure.2010.12.011","volume":"20","author":"SR Jahromi","year":"2011","unstructured":"Jahromi SR, Togha M, Fesharaki SH, Najafi M, Moghadam NB, Kheradmand JA, Kazemi H, Gorji A (2011) Gastrointestinal adverse effects of antiepileptic drugs in intractable epileptic patients. Seizure 20(4):343\u2013346. https:\/\/doi.org\/10.1016\/j.seizure.2010.12.011","journal-title":"Seizure"},{"issue":"3","key":"2525_CR18","doi-asserted-by":"publisher","first-page":"167","DOI":"10.5455\/msm.2015.27.167-171","volume":"27","author":"R Koliqi","year":"2015","unstructured":"Koliqi R, Polidori C, Islami H (2015) Prevalence of side effects treatment with carbamazepine and other antiepileptics in patients with epilepsy. Materia Socio-Medica 27(3):167\u2013171. https:\/\/doi.org\/10.5455\/msm.2015.27.167-171","journal-title":"Materia Socio-Medica"},{"issue":"4","key":"2525_CR19","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1055\/s-2008-1073024","volume":"25","author":"R Korinthenberg","year":"1994","unstructured":"Korinthenberg R, Haug C, Hannak D (1994) The metabolization of carbamazepine to CBZ-10,11-epoxide in children from the newborn age to adolescence. Neuropediatrics 25(4):214\u2013216. https:\/\/doi.org\/10.1055\/s-2008-1073024","journal-title":"Neuropediatrics"},{"issue":"6262","key":"2525_CR20","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1136\/bmj.282.6262.440","volume":"282","author":"T Lee","year":"1981","unstructured":"Lee T, Cochrane GM, Amlot P (1981) Pulmonary eosinophilia and asthma associated with carbamazepine. Br Med J (clin Res Ed) 282(6262):440. https:\/\/doi.org\/10.1136\/bmj.282.6262.440","journal-title":"Br Med J (clin Res Ed)"},{"issue":"12","key":"2525_CR21","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.1111\/epi.14599","volume":"59","author":"CW Lin","year":"2018","unstructured":"Lin CW, Huang WI, Chao PH, Chen WW, Hsiao FY (2018) Temporal trends and patterns in carbamazepine use, related severe cutaneous adverse reactions, and HLA-B*15:02 screening: a nationwide study. Epilepsia 59(12):2325\u20132339. https:\/\/doi.org\/10.1111\/epi.14599","journal-title":"Epilepsia"},{"issue":"2","key":"2525_CR22","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1136\/jnnp.66.2.249","volume":"66","author":"A Mesec","year":"1999","unstructured":"Mesec A, Rot U, Perkovic T, Lunder T, Sibanc B (1999) Carbamazepine hypersensitivity syndrome presenting as vasculitis of the CNS. J Neurol Neurosurg Psychiatry 66(2):249\u2013250. https:\/\/doi.org\/10.1136\/jnnp.66.2.249","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"6","key":"2525_CR23","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1111\/tan.13530","volume":"93","author":"KA Mullan","year":"2019","unstructured":"Mullan KA, Anderson A, Illing PT, Kwan P, Purcell AW, Mifsud NA (2019) HLA-associated antiepileptic drug-induced cutaneous adverse reactions. HLA 93(6):417\u2013435. https:\/\/doi.org\/10.1111\/tan.13530","journal-title":"HLA"},{"issue":"1","key":"2525_CR24","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1002\/cpt.683","volume":"102","author":"RY Pan","year":"2017","unstructured":"Pan RY, Dao RL, Hung SI, Chung WH (2017) Pharmacogenomic advances in the prediction and prevention of cutaneous idiosyncratic drug reactions. Clin Pharmacol Ther 102(1):86\u201397. https:\/\/doi.org\/10.1002\/cpt.683","journal-title":"Clin Pharmacol Ther"},{"issue":"Suppl 3","key":"2525_CR25","doi-asserted-by":"publisher","first-page":"S64","DOI":"10.1111\/j.1528-1157.1987.tb05780.x","volume":"28","author":"JM Pellock","year":"1987","unstructured":"Pellock JM (1987) Carbamazepine side effects in children and adults. Epilepsia 28(Suppl 3):S64\u2013S70. https:\/\/doi.org\/10.1111\/j.1528-1157.1987.tb05780.x","journal-title":"Epilepsia"},{"issue":"5","key":"2525_CR26","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1111\/j.1445-5994.1982.tb03835.x","volume":"12","author":"WP Sheridan","year":"1982","unstructured":"Sheridan WP, King RW, Gerstman M (1982) Fever as an adverse reaction to carbamazepine. Aust N Z J Med 12(5):520\u2013522. https:\/\/doi.org\/10.1111\/j.1445-5994.1982.tb03835.x","journal-title":"Aust N Z J Med"},{"issue":"10","key":"2525_CR27","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1136\/adc.58.10.833","volume":"58","author":"J Tolmie","year":"1983","unstructured":"Tolmie J, Steer CR, Edmunds AT (1983) Pulmonary eosinophilia associated with carbamazepine. Arch Dis Child 58(10):833\u2013834. https:\/\/doi.org\/10.1136\/adc.58.10.833","journal-title":"Arch Dis Child"},{"issue":"2","key":"2525_CR28","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1007\/s10620-017-4881-7","volume":"63","author":"W Tuqan","year":"2018","unstructured":"Tuqan W, Lee S, Hanson J, McCarthy D (2018) Carbamazepine-associated hypersensitivity colitis. Dig Dis Sci 63(2):334\u2013337. https:\/\/doi.org\/10.1007\/s10620-017-4881-7","journal-title":"Dig Dis Sci"},{"issue":"2","key":"2525_CR29","doi-asserted-by":"publisher","first-page":"77","DOI":"10.5415\/apallergy.2016.6.2.77","volume":"6","author":"J Yun","year":"2016","unstructured":"Yun J, Cai F, Lee FJ, Pichler WJ (2016) T-cell-mediated drug hypersensitivity: immune mechanisms and their clinical relevance. Asia Pac Allergy 6(2):77\u201389. https:\/\/doi.org\/10.5415\/apallergy.2016.6.2.77","journal-title":"Asia Pac Allergy"},{"issue":"7","key":"2525_CR30","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1111\/j.1528-1167.2007.01041.x","volume":"48","author":"G Zaccara","year":"2007","unstructured":"Zaccara G, Franciotta D, Perucca E (2007) Idiosyncratic adverse reactions to antiepileptic drugs. Epilepsia 48(7):1223\u20131244. https:\/\/doi.org\/10.1111\/j.1528-1167.2007.01041.x","journal-title":"Epilepsia"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-023-02525-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-023-02525-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-023-02525-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T06:12:50Z","timestamp":1697004770000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-023-02525-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,18]]},"references-count":30,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["2525"],"URL":"https:\/\/doi.org\/10.1007\/s00210-023-02525-2","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,18]]},"assertion":[{"value":"10 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Office of Research Affairs of King Faisal Specialist Hospital and Research Centre on 15th September 2021 under the approval number RAC # 2211128 and publication approval number 2235007. The study was performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}